MORROW GEORGE J 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Nov 26, 2025
Insider Transaction Report
Form 4
MORROW GEORGE J
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-25$47.89/sh+15,000$718,350→ 22,068 total - Sale
Common Stock
2025-11-25$143.37/sh−15,000$2,150,513→ 7,068 total - Exercise/Conversion
Non-Qualified Stock Option
2025-11-25−15,000→ 0 totalExercise: $47.89Exp: 2026-05-20→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2025. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $141.51 to $144.57. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The option was granted May 20, 2016 and vested in 12 equal monthly installments beginning June 20, 2016. These options were due to expire on May 20, 2026.